resveratrol has been researched along with Pulmonary Arterial Hypertension in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bomfim, MRQ; Brito-Monzani, JO; Dias, CJ; Dias-Filho, CAA; Durans, R; Ferreira, AC; Maciel, AWS; Mostarda, CT; Pereira Costa, JM; Serejo, JS; Vieira, ASM | 1 |
| Acuña-Morín, E; Bernal-Ramírez, J; Chapoy-Villanueva, H; García-Rivas, G; Jerjes-Sánchez, C; Lozano, O; Pérez-Plata, L; Ramírez-Rivera, A; Ramos-González, MR; Sánchez-Trujillo, L; Torre-Amione, G; Vanoye-Tamez, M; Vázquez-Garza, E | 1 |
| Han, X; Li, Z; Ma, M; Qiao, W; Tang, J; Wang, C; Wang, H | 1 |
| Chen, G; Chen, S; Fan, Y; Hao, X; Qin, Z; Qu, H; Sun, X; Zhao, B | 1 |
| Bernal-Ramírez, J; Chapoy-Villanueva, H; García, N; García-Rivas, G; Jerjes-Sánchez, C; Ramírez-Rivera, A; Ramos-González, MR; Silva-Platas, C; Vázquez-Garza, E; Zarain-Herzberg, Á | 1 |
1 review(s) available for resveratrol and Pulmonary Arterial Hypertension
| Article | Year |
|---|---|
Dose-related Effects of Resveratrol in Different Models of Pulmonary Arterial Hypertension: A Systematic Review.
Topics: Animals; Antioxidants; Disease Models, Animal; Humans; Male; Mice; Pulmonary Arterial Hypertension; Resveratrol | 2020 |
4 other study(ies) available for resveratrol and Pulmonary Arterial Hypertension
| Article | Year |
|---|---|
Resveratrol Prevents Right Ventricle Remodeling and Dysfunction in Monocrotaline-Induced Pulmonary Arterial Hypertension with a Limited Improvement in the Lung Vasculature.
Topics: Animals; Antioxidants; Disease Models, Animal; Echocardiography; Lung; Male; Pulmonary Arterial Hypertension; Rats; Rats, Sprague-Dawley; Resveratrol; Ventricular Remodeling | 2020 |
DPPC-coated lipid nanoparticles as an inhalable carrier for accumulation of resveratrol in the pulmonary vasculature, a new strategy for pulmonary arterial hypertension treatment.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Animals; Cell Proliferation; Cell Survival; Cells, Cultured; Drug Carriers; Drug Liberation; Drug Stability; Glycerides; Lung; Male; Myocytes, Smooth Muscle; Nanoparticles; Particle Size; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats, Sprague-Dawley; Resveratrol; Surface Properties | 2020 |
Sera and lungs metabonomics reveals key metabolites of resveratrol protecting against PAH in rats.
Topics: Animals; Biomarkers; Chromatography, High Pressure Liquid; Disease Models, Animal; Energy Metabolism; Hypoxia; Lung; Male; Metabolomics; Pulmonary Arterial Hypertension; Rats, Wistar; Resveratrol; Spectrometry, Mass, Electrospray Ionization | 2021 |
Resveratrol Prevents Right Ventricle Dysfunction, Calcium Mishandling, and Energetic Failure via SIRT3 Stimulation in Pulmonary Arterial Hypertension.
Topics: Animals; Antioxidants; Calcium; Humans; Male; Pulmonary Arterial Hypertension; Rats; Rats, Sprague-Dawley; Resveratrol; Sirtuin 3; Ventricular Dysfunction, Right | 2021 |